TSH receptor antibodies have predictive value for breast cancer - Retrospective analysis

Thyroid Research

Volumn 6, Issue 1, 2013, Pages

  Szychta, Paweł ^a,b   Szychta, Wojciech ^a,c   Gesing, Adam ^a   Lewiński, Andrzej ^a,b   Karbownik Lewińska, Małgorzata ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Autoimmune disease; Breast cancer; Graves' disease; Thyroglobulin antibody; Thyroid; Thyroperoxidase antibody; TSH; TSH receptor antibody

Indexed keywords

THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ARTICLE; BREAST CANCER; BREAST TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAVES DISEASE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; THYROID DISEASE;

EID: 84878142898     PISSN: None     EISSN: 17566614     Source Type: Journal    
DOI: 10.1186/1756-6614-6-8     Document Type: Article

References (47)

1. Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Dinda S, Sanchez A, Moudgil V, Oncogene 2002 21 761 768 10.1038/sj.onc.1205136 11850804 (Pubitemid 34146288)
2. Influence of thyroid hormone receptors on breast cancer cell proliferation. Conde I, Paniagua R, Zamora J, Blanquez MJ, Fraile B, Ruiz A, Arenas MI, Ann Oncol 2006 17 60 64 16282247 (Pubitemid 43033841)
3. Breast cancer in association with thyroid disorders. Turken O, NarIn Y, DemIrbas S, Onde ME, Sayan O, KandemIr EG, YaylacI M, Ozturk A, Breast Cancer Res 2003 5 110 R113 10.1186/bcr609 12927040
4. Thyroid function and cancer risk: a prospective population study. Hellevik AI, Asvold BO, Bjøro T, Romundstad PR, Nilsen TI, Vatten LJ, Cancer Epidemiol Biomarkers Prev 2009 18 570 574 10.1158/1055-9965.EPI-08-0911 19155436
5. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Malm J, Manjer J, Breast Cancer Res 2010 12 33 10.1186/bcr2587 20540734
6. Early-onset breast cancer in a woman with Graves' disease. Siegler JE, Li X, Jones SD, Kandil E, Int J Clin Exp Med 2012 5 358 362 22993658
7. Mechanisms in endocrinology: primary HT and risk for breast cancer: a systematic review and meta-analysis. Angelousi AG, Anagnostou VK, Stamatakos MK, Georgiopoulos GA, Kontzoglou KC, Eur J Endocrinol 2012 166 373 381 10.1530/EJE-11-0838 22023791
8. Breast cancer in patients with Hashimoto's thyroiditis. Ito K, Maruchi N, Lancet 1975 2 1119 1121 53602
9. Breast cancer relationship to thyroid supplements for hypothyroidism. Kapdi JJ, Wolfe JN, JAMA 1976 236 1124 1127 10.1001/jama.1976.03270110022020 988872
10. Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Nelson M, Hercbergs A, Rybicki L, Strome M, Arch Otolaryngol Head Neck Surg 2006 132 1041 1046 10.1001/archotol.132.10. 1041 17043248 (Pubitemid 44600780)
11. Hashimoto's thyroiditis and breast cancer. Maruchi N, Annegers JF, Kurland LT, Mayo Clin Proc 1976 51 263 265 946676
12. A patient with Graves' disease showing only psychiatric symptoms and negativity for both TSH receptor autoantibody and thyroid stimulating antibody. Hamasaki H, Yoshimi T, Yanai H, Thyroid Res 2012 5 19 10.1186/1756-6614-5-19 23206540
13. The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue. Oh HJ, Chung JK, Kang JH, Kang WJ, Noh DY, Park IA, Jeong JM, Lee DS, Lee MC, Cancer Res Treat 2005 37 247 250 10.4143/crt.2005.37.4.247 19956522
14. Incidence of malignant neoplasms of all types of patients with Graves' disease. Munoz JM, Gorman CA, Elveback LR, Wentz JR, Arch Intern Med 1978 138 944 947 10.1001/archinte.1978.03630310034015 580555 (Pubitemid 9006064)
15. Cancer risk in patients with Graves' disease: A nationwide cohort study. Chen YK, Lin CL, Chang YJ, Cheng FT, Peng CL, Sung FC, Cheng YH, Kao CH, Thyroid in press
16. Benign thyroid disease is associated with breast cancer: a meta-analysis. Hardefeldt PJ, Eslick GD, Edirimanne S, Breast Cancer Res Treat 2012 133 1169 1177 10.1007/s10549-012-2019-3 22434524
17. Is there a role for iodine in breast diseases? Venturi S, Breast 2001 10 379 382 10.1054/brst.2000.0267 14965610 (Pubitemid 33061858)
18. Autoimmune thyroid diseases in women with breast cancer and colorectal cancer. Jiskra J, Límanová Z, Barkmanová J, Smutek D, Friedmannová Z, Physiol Res 2004 53 693 702 15588139 (Pubitemid 40065700)
19. The thyroid, iodine and breast cancer. Smyth PP, Breast Cancer Res 2003 5 235 238 10.1186/bcr638 12927031 (Pubitemid 37080851)
20. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. Giani C, Fierabracci P, Bonacci R, Gigliotti A, Campani D, De Negri F, Cecchetti D, Martino E, Pinchera A, J Clin Endocrinol Metab 1996 81 990 994 10.1210/jc.81.3.990 8772562 (Pubitemid 26083958)
21. Serum thyroid peroxidase autoantibodies, thyroid volume and outcome in breast cancer. Smyth PPA, Shering S, Kilbane MT, Murray MJ, McDermott EWM, Smith DF, O'Higgins NJ, J Clin Endocrinol Metab 1998 83 2711 2716 10.1210/jc.83.8.2711 9709936 (Pubitemid 28493765)
22. Hypothyroidism might be related to breast cancer in post-menopausal women. Kuijpens JL, Nyklíctek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW, Thyroid 2005 15 1253 1259 10.1089/thy.2005.15.1253 16356089 (Pubitemid 41821759)
23. Do thyroid disorders increase the risk of breast cancer? Simon MS, Tang MT, Bernstein L, Norman SA, Weiss L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone K, Marchbanks PA, McDonald JA, Strom BL, Wilson HG, Spirtas R, Cancer Epidemiol Biomarkers Prev 2002 11 1574 1578 12496046 (Pubitemid 36020009)
24. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Latif R, Morshed SA, Zaidi M, Davies TF, Endocrinol Metab Clin North Am 2009 38 319 341 10.1016/j.ecl.2009.01.006 19328414
25. Evaluation of efficacy of iodine prophylaxis in Poland based on the examination of schoolchildren living in Opoczno Town (Lodz Voivodship). Zygmunt A, Adamczewski Z, Wojciechowska-Durczyńska K, Cyniak-Magierska A, Krawczyk-Rusiecka K, Zygmunt A, Karbownik-Lewińska M, Lewiński A, Thyroid Res 2012 5 23 10.1186/1756-6614-5-23 23259538
26. Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. Mittra I, Perrin J, Kumaoka S, BMJ 1976 1 257 259 10.1136/bmj.1.6004.257 1082357
27. Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. Kilbane MT, Ajjan RA, Weetman AP, Dwyer R, McDermott EW, O'Higgins NJ, Smyth PP, J Clin Endocrinol Metab 2000 85 1245 1250 10.1210/jc.85.3.1245 10720070 (Pubitemid 32269380)
28. Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer? Beyer SJ, Jimenez RE, Shapiro CL, Cho JY, Jhiang SM, Breast Cancer Res Treat 2009 115 205 212 10.1007/s10549-008-0059-5 18500672
29. Will radioiodine be useful in treatment of breast cancer? Daniels GH, Haber DA, Nat Med 2000 6 859 860 10.1038/78604 10932214 (Pubitemid 30644737)
30. Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers? Boelaert K, Franklyn JA, Lancet 2003 361 796 797 10.1016/S0140-6736(03)12720-1 12642042 (Pubitemid 36331838)
31. Growth factors controlling the thyroid gland. Dumont JE, Maenhaut C, Baillieres Clin Endocrinol Metabol 1991 5 727 753 10.1016/S0950-351X(10)80012-6
32. Thyroid function during pregnancy and the postpartum period: iodine metabolism and disease states. Fernández-Soto ML, Jovanovic LG, González-Jiménez A, Lobón-Hernández JA, Escobar-Jiménez F, López-Cózar LN, Barredo-Acedo F, Campos-Pastor MM, López-Medina JA, Endocr Pract 1998 4 97 105 10.4158/EP.4.2.97 15251754
33. Oxidative damage to macromolecules in the thyroid-experimental evidence. Karbownik-Lewińska M, Kokoszko-Bilska A, Thyroid Res 2012 5 25 10.1186/1756-6614-5-25 23270549
34. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Giustarini E, Pinchera A, Fierabracci P, Roncella M, Fustaino L, Mammoli C, Giani C, Eur J Endocrinol 2006 154 645 649 10.1530/eje.1.02108 16645010 (Pubitemid 43810849)
35. Relationship between the levels of Serum Thyroid Hormones and the Risk of Breast Cancer. Ali A, Mir MR, Bashir S, Hassan T, Bhat SA, J Biol Agr Healthc 2011 2 56 60
36. Profile of thyroid hormones in breast cancer patients. Saraiva PP, Figueiredo NB, Padovani CR, Brentani MM, Nogueira CR, Braz J Med Biol Res 2005 38 761 765 15917958 (Pubitemid 40867516)
37. Autoimmune thyroid disease and breast cancer: a chance association. Smyth PPA, J Endocrinol Invest 2000 23 42 43 10698051 (Pubitemid 30105319)
38. Phylogenetic analysis of the human thyroglobulin regions. Belkadi A, Jacques C, Savagner F, Malthièry Y, Thyroid Res 2012 5 3 10.1186/1756-6614-5-3 22549183
39. Factors associated with serum thyroglobulin levels in a population living in Belarus. Cahoon EK, Rozhko A, Hatch M, Polyanskaya O, Ostroumova E, Tang M, Nadirov E, Yauseyenka V, Savasteeva I, McConnell RJ, Pfeiffer RM, Brenner AV, Clin Endocrinol (Oxf) 2012 in press
40. Autoantibodies and Autoimmune Disease During Treatment of Children With Chronic Hepatitis C. Molleston JP, Mellman W, Narkewicz MR, Balistreri WF, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Mohan P, Murray KF, Njoku D, Rosenthal P, Barton BA, Talor MV, Cheng I, Schwarz KB, Haber BA, for the PEDS-C Clinical Research Network, J Pediatr Gastroenterol Nutr 2013 56 304 310 10.1097/MPG.0b013e3182774cae 23439301
41. Thyroglobulin antibodies in 1,297 patients without thyroid disease. Hill OW, Br Med J 1961 5242 1793 1796
42. Population screening for autoimmune thyroid disease. Tunbridge WM, Vanderpump MP, Endocrinol Metab Clin North Am 2000 29 239 253 10.1016/S0889-8529(05)70129-8 10874527 (Pubitemid 30396228)
43. Mastopathy and simple goiter-mutual relationships. Mizia-Stec K, Zych F, Widala E, Przegl Lek 1998 55 250 258 9741192
44. The TSH receptor and its role in thyroid disease. Kopp P, Cell Mol Life Sci 2001 58 1301 1322 10.1007/PL00000941 11577986 (Pubitemid 32844100)
45. Update in TSH receptor agonists and antagonists. Gershengorn MC, Neumann S, J Clin Endocrinol Metab 2012 97 4287 4292 10.1210/jc.2012-3080 23019348
46. Autoimmune thyroid disorders-An update. Swain M, Swain T, Mohanty BK, Indian J Clin Biochem 2005 20 9 17 10.1007/BF02893034 23105486
47. The thyroid gland and the process of aging; what is new? Gesing A, Lewiński A, Karbownik-Lewińska M, Thyroid Res 2012 5 16 10.1186/1756-6614-5-16 23176389